Literature DB >> 12921637

[Down-regulated full-length novel gene GDDR and its effect on gastric cancer].

Jian-jun Du1, Ke-feng Dou, Shu-you Peng, Wei-zhong Wang, Zhong-hua Wang, Hua-sheng Xiao, Wen-xian Guan, Ying-bin Liu, Zhi-qing Gao.   

Abstract

OBJECTIVE: To clone gene fragments from suppression substructive library established for screening down-regulated genes in gastric carcinoma, and obtain the full-length novel gene.
METHODS: Gene fragments were identified by sequencing plasmids of positive colonies chosen randomly. One gene fragment was amplified by RACE, and the full-length novel gene was obtained. Expression of novel gene mRNA was respectively detected by semi-quantitative PCR in the gastric carcinoma tissues and counterpart normal gastric mucous membrane of 25 patients with gastric cancer. The structure of the full-length novel gene, location on chromosome, property of protein encoded by full-length novel gene and its function were investigated by Bio-message technique.
RESULTS: One 331 bp gene fragment was cloned, and its full-length novel gene obtained by RACE. The novel full-length gene was named GDDR, registered in the number of AF494509 by GenBank. Significant down-regulated expression of GDDR gene mRNA in gastric carcinoma tissues was confirmed (GDDR/beta-actin 13.474 +/- 5.059 vs 1.041 +/- 0.202, P < 0.01). GDDR was located in chromosome 2p13 with 5 exons. As one member of new BRICHO family as CA11, GDDR encoding protein with transmembrane peptide revealed homology to protein encoded by CA11.
CONCLUSION: A novel full-length gene GDDR is obtained. GDDR likely is another gene of BRICHO family related to gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921637

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  18 in total

1.  Gastrokine-2 is downregulated in gastric cancer and its restoration suppresses gastric tumorigenesis and cancer metastasis.

Authors:  Jin Dai; Ning Zhang; Jinhui Wang; Minhu Chen; Jie Chen
Journal:  Tumour Biol       Date:  2014-01-10

2.  Gastrointestinal tract specific gene GDDR inhibits the progression of gastric cancer in a TFF1 dependent manner.

Authors:  Guanghui Chu; Shengbin Qi; Guodong Yang; Kefeng Dou; Jianjun Du; Zifan Lu
Journal:  Mol Cell Biochem       Date:  2011-08-26       Impact factor: 3.396

3.  Gastrokine-2 suppresses epithelial mesenchymal transition through PI3K/AKT/GSK3β signaling in gastric cancer.

Authors:  Jin Dai; Chenchen Qian; Mingli Su; Minhu Chen; Jie Chen
Journal:  Tumour Biol       Date:  2016-06-21

4.  Gastrointestinal Factor GDDR Attenuates Epithelial-Mesenchymal Transition in Gastric Cancer via Inhibiting AKT Signal.

Authors:  Cheng Fang; Ziqiang Zhang; Chaoxu Liu; Gang Wang; Fei Wang; Zhanwei Zhao; Wenhui Li; Jin Hua; Jianbo Shuang; Jianjun Du
Journal:  Dig Dis Sci       Date:  2016-03-26       Impact factor: 3.199

5.  Gene expression profiling reveals sequential changes in gastric tubular adenoma and carcinoma in situ.

Authors:  Chang-Hee Lee; Seung-Hyun Bang; Seung-Koo Lee; Kyu-Young Song; In-Chul Lee
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

6.  Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2.

Authors:  Fabian B Fahlbusch; Matthias Ruebner; Hanna Huebner; Gudrun Volkert; Hannah Bartunik; Ilona Winterfeld; Andrea Hartner; Carlos Menendez-Castro; Stephanie C Noegel; Ines Marek; David Wachter; Regine Schneider-Stock; Matthias W Beckmann; Sven Kehl; Wolfgang Rascher
Journal:  Histochem Cell Biol       Date:  2015-06-13       Impact factor: 4.304

7.  Detection of β-catenin, gastrokine-2 and embryonic stem cell expressed ras in gastric cancers.

Authors:  Fan Zhang; Jian Min Tang; Li Wang; Jing Ying Shen; Lin Zheng; Ping Ping Wu; Mei Zhang; Zhao Wen Yan
Journal:  Int J Clin Exp Pathol       Date:  2010-11-01

8.  Evolution of the human gastrokine locus and confounding factors regarding the pseudogenicity of GKN3.

Authors:  Jessica H Geahlen; Carlo Lapid; Kaisa Thorell; Igor Nikolskiy; Won Jae Huh; Edward L Oates; Jochen K M Lennerz; Xiaolin Tian; Victoria G Weis; Shradha S Khurana; Samuel B Lundin; Alan R Templeton; Jason C Mills
Journal:  Physiol Genomics       Date:  2013-05-28       Impact factor: 3.107

9.  Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.

Authors:  Trevelyan R Menheniott; Louise O'Connor; Yok Teng Chionh; Jan Däbritz; Michelle Scurr; Benjamin N Rollo; Garrett Z Ng; Shelley Jacobs; Angelique Catubig; Bayzar Kurklu; Stephen Mercer; Toshinari Minamoto; David E Ong; Richard L Ferrero; James G Fox; Timothy C Wang; Philip Sutton; Louise M Judd; Andrew S Giraud
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

10.  Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis.

Authors:  Steven F Moss; Jin-Woo Lee; Edmond Sabo; Anna K Rubin; John Rommel; Bruce R Westley; Felicity E B May; John Gao; Patricia A Meitner; Rose Tavares; Murray B Resnick
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.